Image quality in abdominal CT using an iodine contrast reduction algorithm employing patient size and weight and low kV CT technique.


Journal

Acta radiologica (Stockholm, Sweden : 1987)
ISSN: 1600-0455
Titre abrégé: Acta Radiol
Pays: England
ID NLM: 8706123

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 29 1 2020
medline: 12 9 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Low tube potential-high tube current computed tomography (CT) imaging allows reduction in iodine-based contrast dose and may extend the benefit of routine contrast-enhanced CT exams to patients at risk of nephrotoxicity. To determine the ability of an iodine contrast reduction algorithm to maintain diagnostic image quality for contrast-enhanced abdominal CT. CT exams with iodine contrast reduction were prescribed for patients at risk for renal dysfunction. The iodine contrast reduction algorithm combines weight-based contrast volume reduction with patient width-based low tube potential selection and bolus-tracking. Control exams with routine iodine dose were selected based on weight, width, and scan protocol. Three radiologists evaluated image quality and diagnostic confidence using a 4-point scale (<2 acceptable). Another radiologist assessed contrast reduction indications and measured portal vein and liver contrast-to-noise ratios. Forty-six contrast reduction algorithm and control exams were compared (mean creatinine 1.6 vs. 1.2 mg/dL, This size-based contrast reduction algorithm using low kV and bolus tracking reduced iodine contrast dose by 50%, while achieving acceptable image quality in 95% of exams.

Sections du résumé

BACKGROUND BACKGROUND
Low tube potential-high tube current computed tomography (CT) imaging allows reduction in iodine-based contrast dose and may extend the benefit of routine contrast-enhanced CT exams to patients at risk of nephrotoxicity.
PURPOSE OBJECTIVE
To determine the ability of an iodine contrast reduction algorithm to maintain diagnostic image quality for contrast-enhanced abdominal CT.
MATERIAL AND METHODS METHODS
CT exams with iodine contrast reduction were prescribed for patients at risk for renal dysfunction. The iodine contrast reduction algorithm combines weight-based contrast volume reduction with patient width-based low tube potential selection and bolus-tracking. Control exams with routine iodine dose were selected based on weight, width, and scan protocol. Three radiologists evaluated image quality and diagnostic confidence using a 4-point scale (<2 acceptable). Another radiologist assessed contrast reduction indications and measured portal vein and liver contrast-to-noise ratios.
RESULTS RESULTS
Forty-six contrast reduction algorithm and control exams were compared (mean creatinine 1.6 vs. 1.2 mg/dL,
CONCLUSION CONCLUSIONS
This size-based contrast reduction algorithm using low kV and bolus tracking reduced iodine contrast dose by 50%, while achieving acceptable image quality in 95% of exams.

Identifiants

pubmed: 31986894
doi: 10.1177/0284185119898655
doi:

Substances chimiques

Contrast Media 0
Iodine 9679TC07X4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1186-1195

Auteurs

Veena R Iyer (VR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Eric C Ehman (EC)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Ashish Khandelwal (A)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Michael L Wells (ML)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Yong S Lee (YS)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Nikkole M Weber (NM)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Matthew P Johnson (MP)

Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

Lifeng Yu (L)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Cynthia H McCollough (CH)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Joel G Fletcher (JG)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH